TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 136nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair